Astrazeneca and EU settle missing vaccines case

The case of the missing delivery of Covid-19 vaccines won't make it to court as the two parties agree to settle.

Photo: Athit Perawongmetha/Reuters/Ritzau Scanpix

Just short of a month before the Astrazeneca-EU lawsuit date, both parties have now agreed to a settlement, according to statements Friday morning.

The case concerns a dispute that began in spring regarding delivery of Astrazeneca Covid-19 vaccine Vaxzevria. At the time, Astrazeneca was unable to deliver the vaccine doses that the EU was entitled to according to the deal from the preceding year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs